Clinical Trial Update: Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epoetin alfa for Friedreich's ataxia has completed enrollment and reported efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Federico II University | Conditions: Friedreich's Ataxia | Phase 2 | Status: COMPLETED